Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis
ADVstudio2021-02-25T19:24:27+00:00Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis
Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis
Cytocast can simulate drugs acting on surface protein receptors
Cytocast can simulate the transcriptional modification caused by drug administration.
Personalized medicine is an emerging practice that uses an individual’s molecular and genetic profile to guide treatment decisions for each patient. Computational systems biology is [...]
See cytocast in action on our DEMO page. Do you want to use our simulator? Get in touch with us. Cytocast whole cell simulator© is [...]
Treat the patient not the statistics Cytocast offers an educational and research tool for life and computational scientists to illustrate and understand complex biological processes [...]
Treat the patient not the statistics Many drugs fail at a late stage in clinical trials because the drug is not as effective as previously [...]
How can a computer simulation help doctors to decide the right treatment for the patient? Flight simulators are widely used to train and test pilots. [...]
The Cytocast vision is to change personalized medicine. Make it fully predictable by the most detailed model of a cell. Cytocast started a long path from an early scientific [...]
Drug development companies can use Cytocast Whole Cell Simulator to accelerate drug development.